Open Access

Downregulation of CUEDC2 prevents doxorubicin‑induced cardiotoxicity in H9c2 cells

  • Authors:
    • Xianpu Zhang
    • Jiaojiao Li
    • Yongbo Cheng
    • Jianguang Yi
    • Xin Liu
    • Wei Cheng
  • View Affiliations

  • Published online on: May 23, 2018     https://doi.org/10.3892/mmr.2018.9072
  • Pages: 855-863
  • Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Treatment with doxorubicin (DOX), which is an effective anticancer agent, is limited by cardiotoxicity. CUE domain‑containing 2 (CUEDC2) serves a role in numerous cellular processes. The present study aimed to elucidate the potential function of CUEDC2 in DOX‑induced cardiotoxicity. Cell Counting kit‑8 assay demonstrated that DOX induced cytotoxicity of H9c2 cells in a dose‑dependent manner. Flow cytometry demonstrated that downregulation of CUEDC2 reduced the levels of DOX‑induced reactive oxygen species. Furthermore, compared with in the DOX‑treated group, the activity of superoxide dismutase was increased in the DOX + small interfering RNA (si)CUEDC2 group; whereas, the malondialdehyde content was reduced in the DOX + siCUEDC2 group. In addition, flow cytometric analysis indicated that mitochondrial membrane potential was maintained following the depletion of CUEDC2. Furthermore, CUEDC2 downregulation significantly inhibited DOX‑induced apoptosis. The expression levels of proapoptotic genes, including B‑cell lymphoma 2 (Bcl‑2)‑associated X protein, cleaved caspase‑3 and cytochrome c were inhibited by the depletion of CUEDC2. Conversely, the expression levels of the anti‑apoptotic gene Bcl‑2 were elevated in the CUEDC2 knockdown group. Downregulation of CUEDC2 also increased phosphorylation of protein kinase B and forkhead box O3a, and decreased the expression of Bcl‑2‑like protein 11 according to western blot analysis. Taken together, the present study demonstrated that CUEDC2 downregulation prevented DOX‑induced cardiotoxicity in H9c2 cells. Therefore, CUEDC2 may be a promising target for the prevention of DOX‑induced cardiotoxicity.
View Figures
View References

Related Articles

Journal Cover

July-2018
Volume 18 Issue 1

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Zhang X, Li J, Cheng Y, Yi J, Liu X and Cheng W: Downregulation of CUEDC2 prevents doxorubicin‑induced cardiotoxicity in H9c2 cells. Mol Med Rep 18: 855-863, 2018
APA
Zhang, X., Li, J., Cheng, Y., Yi, J., Liu, X., & Cheng, W. (2018). Downregulation of CUEDC2 prevents doxorubicin‑induced cardiotoxicity in H9c2 cells. Molecular Medicine Reports, 18, 855-863. https://doi.org/10.3892/mmr.2018.9072
MLA
Zhang, X., Li, J., Cheng, Y., Yi, J., Liu, X., Cheng, W."Downregulation of CUEDC2 prevents doxorubicin‑induced cardiotoxicity in H9c2 cells". Molecular Medicine Reports 18.1 (2018): 855-863.
Chicago
Zhang, X., Li, J., Cheng, Y., Yi, J., Liu, X., Cheng, W."Downregulation of CUEDC2 prevents doxorubicin‑induced cardiotoxicity in H9c2 cells". Molecular Medicine Reports 18, no. 1 (2018): 855-863. https://doi.org/10.3892/mmr.2018.9072